Rabeprazole 117976-89-3

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex ({{IPA-en

read more [+]

Systematic (IUPAC) name:	(RS)-2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole
Rabeprazole CAS number:	117976-89-3
ATC code:	A02BC04
PubChem:	5029
DrugBank:	APRD01212
Formula:	C18H21N3O3
Molecular mass:	359.444 g/mol
Rabeprazole Assay/Purity:	Typically NLT 98%

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.